|Bid||24.03 x 1100|
|Ask||24.02 x 1800|
|Day's Range||23.67 - 24.10|
|52 Week Range||17.96 - 24.50|
|PE Ratio (TTM)||13.79|
|Earnings Date||Jul 25, 2018 - Jul 30, 2018|
|Forward Dividend & Yield||0.68 (2.84%)|
|1y Target Est||27.00|
Jim Chanos, Kynikos Associates, talks about his short position in Tesla and what he thinks about the company's prospects for the future.
Jun.11 -- KKR & Co. will acquire Envision Healthcare Corp. in a deal worth $5.57 billion. Bloomberg's Jason Kelly reports on "Bloomberg Daybreak: Americas."
The portfolio, which includes the Babies ‘R’ Us and Geoffrey character trademark, has more than 115 potential bidders.
Stock movements reflect premarket trading. asking his administration to identify a new list of $200 billion in Chinese goods that would be penalized with tariffs, a move that could affect multinational industrial firms like Boeing. Apple Inc.—Down 1.8%: The New York Times reported that the Trump administration has promised not to place tariffs on iPhones, which are manufactured in China.
MADRID/LONDON (Reuters) - Private equity firm KKR (KKR.N) is close to buying a stake in the telecom towers business of Altice (ATCA.AS), three sources told Reuters, a deal that will help the telecoms and cable group to pay down debt and reshape its European operations. Under the deal, which is being finalised, KKR will use its infrastructure fund to take a minority interest in Altice's towers subsidiary in France, the sources said.
MIAMI , June 14, 2018 /PRNewswire/ -- KKR and Parkway Property Investments, LLC ("Parkway") announced today the acquisition of 1111 Brickell, a 30-story, approximately 522,000 square foot Class ...
Private equity firm KKR & Co’s US$9.9bn leveraged buyout (LBO) of physician service provider Envision Healthcare has helped boost private equity deal volumes to levels not seen since before the credit crisis. Global private equity-backed merger & acquisition (M&A) volume stands at US$191.7bn this year, which is up 39% over last year at this time and the highest level since 2007 when volume had already topped US$350bn by June 11, according to data from Thomson Reuters Deals Intelligence. The buyout flurry comes as private equity firms look to take advantage of supportive credit markets, coupled with a record amount of dry powder available for purchases.
LONDON, UK / ACCESSWIRE / June 13, 2018 / If you want a free Stock Review on KKR sign up now at www.wallstequities.com/registration. WallStEquities.com revisits the Asset Management space, which comprises people who and companies that manage investments on behalf of others. Under assessment this morning are the following four stocks: Janus Henderson Group PLC (NYSE: JHG), KKR & Co. L.P. (NYSE: KKR), Legg Mason Inc. (NYSE: LM), and Northern Trust Corp. (NASDAQ: NTRS).
KKR & Co.’s $8.3 billion purchase of BMC Software Inc. will increase leverage at the firm just two years after an earlier financing for the company drew a warning from regulators over risks in the debt. KKR is buying BMC from a group led by Bain Capital and Golden Gate Capital in a transaction arranged by banks including Credit Suisse Group AG, Goldman Sachs Group Inc. and Jefferies Group LLC, that will push leverage to about 7.5 times a measure of earnings, according to people with knowledge of the deal.
Blackstone Group LP said it has raised about $9.4 billion for two new funds - the largest-ever fund dedicated to real estate investments in Asia as well as its first private equity fund for the region. The funds add to a massive industry-wide pool of money for Asian acquisitions and investments, with investors attracted by rapid economic growth compared to other major markets.
NEW YORK , June 12, 2018 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Envision Healthcare Holdings Inc. ("EVHC" ...
NEW ORLEANS , June 12, 2018 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale ...
Optiv Security, the world’s leading security solutions integrator, today announced it has named Chad Holmes as chief services and operations officer and Nate Brady as chief financial officer, two key appointments that support the company’s global services expansion and business growth strategy.
Landlords have malls they’d like to unload. As they battle the rise of e-commerce, U.S. mall owners are trying to clear their books of fading centers so they can focus on the most-profitable ones. Only about $3 billion of retail real estate changed hands in April, a 27 percent drop from a year earlier and the lowest monthly tally since February 2013, according to the latest data from Real Capital Analytics Inc.
Private-equity firm KKR & Co. has reached a deal to buy Envision Healthcare Corp., a provider of services to hospitals, for about $5.5 billion in cash. On Sunday, The Wall Street Journal reported KKR was nearing a deal for Envision. The all-in price tag makes it one of the largest recent leveraged buyouts.
The big event this week is the summit between President Donald Trump and North Korean leader Kim Jong Un, which begins Tuesday. The Dow last week rose 2.77%, the S&P 500 gained 1.62% and the Nasdaq finished up by 1.21%. Stocks finished higher on Monday, June 11, as Wall Street prepared for an extraordinary week for risk events around the world.
The private equity firm beat peers Carlyle Group (CG.O), TPG Global and others as it sealed the deal for $46 per share - a premium of 5.4 percent to Envision's last close on Friday. KKR already owns Envision's ambulance unit AMR, which it bought for $2.4 billion last year and merged with its helicopter ambulance service. The firm also took WebMD Health Corp (WBMD.O) private for about $2.8 billion.
Health-care outsourcing companies are bad at doing deals, and private equity firms are their fixer of choice. Envision Healthcare Corp. on Monday agreed to sell itself to KKR & Co. for $46 a share, or $9.9 billion including debt. The deal caps a more than six-month strategic review and comes just 18 months after Envision combined with AmSurg Corp.
The S&P 500 edged higher on Monday, helped by gains in bank shares and utility Sempra Energy, as investors looked past a chaotic G7 meeting over the weekend and focused on a historic U.S.-North Korea summit. President Donald Trump threw the G7's efforts to show a united front into disarray after taking aim at Canadian Prime Minister Justin Trudeau and announcing that he was backing out of the joint communique.
Envision Healthcare inked a deal to be bought by KKR & Co. L.P. Unit (NYSE: KKR)for $46 per share, or $9.9 billion in cash. The per-share transaction value represents a 32-percent premium to the volume-weighted average share price from Nov. 1, 2017, the time of announcement of review of strategic options, the company said in a release. After reaching out to 25 potential buyers, Envision said it zeroed in on the KKR deal, as the offer is likely to deliver the most value to its shareholders.
After a seven-month strategic review, healthcare services company Envision Healthcare Corp. said Monday, June 11, it has agreed to sell to private equity firm KKR & Co. KKR will pay $46 a share, marking a 32% premium to Envision's volume-weighted average share price from Nov. 1, 2017, the day after the company announced it had launched a review of strategic options.
Yahoo Finance's LIVE market coverage and analysis of what you need to watch in the stock market begins each day at 9:25 a.m. ET.
Private equity firm KKR & Co. will buy Envision Healthcare Corp. for $5.57 billion plus debt, after a lengthy sale process by the hospital staffing and surgical center company.
Shares of Envision Healthcare Corp. surged 2.5% in premarket trade Monday, after the provider of physician-led services and post-acute care said it agreed to be acquired by KKR & Co. LP in a deal valued at $9.9 billion, including debt. Under terms of the deal, KKR will pay $46 in cash for each Envision share outstanding, a 5.4% premium to Friday's closing price of $43.64. Envision said the deal follows a review of strategic alternatives to enhance shareholder value.